Anti Estrogen CAS 82640-04-8 Raloxifene Hydrochloride for Breast Cancer Osteoporosis
|FOB Price:||US $1.5-12 / gram|
|Min. Order:||10 gram|
|Min. Order||FOB Price|
|10 gram||US $1.5-12/ gram|
|Production Capacity:||800 Kg/Month|
|Transport Package:||10g, 20g, 50g, 100g Per Aluminum Foil Bag|
|Payment Terms:||T/T, Western Union, Money Gram, Bitcoin|
- Model NO.: 82640-04-8
- Customized: Non-Customized
- Suitable for: Elderly, Adult
- Purity: >99%
- Origin: Made in China
- Powder: Yes
- Certification: ISO 9001, SGS, Kosher
- State: Solid
- Trademark: NJBN STEROID
1. Quick Detail:
|Product Name||Raloxifene hydrochloride|
|Alias||Raloxifene HCL; KEOXIFENE|
|Appearance||light yellow powder|
|Storage||Shading, Confined Preservation|
|Brand Name||NJBN STEROID|
Evista (Raloxifene hydrochloride) is an estrogen agonist / antagonist, referred to as a Selective estrogen receptor modulator (SERMs) and belongs to the benzothiophene class of compounds. The biological actions of Raloxifene are largely settlement through binding to estrogen receptors. This binding results in the activation of Pathways to estrogenic in some tissues (agonist) and and the Blockade of estrogenic Foundation in other tissues (antagonist).
Evista is specifically approved for the treatment and prevention of osteoporosis in postmenopausal women, the reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis and the reduction in risk of invasive breast cancer in postmenopausal women at high risk of invasive breast cancer. Evista is supplied as a 60 mg tablet designed for oral administration. The recommended initial of the records about the drug is one 60 mg tablet daily, which may be administered any time of day without regard to meals.
( use in cancer )
Raloxifene hydrochloride is approved to prevent:
Breast cancer. It is used to decrease the chance of invasive breast cancer in postmenopausal women who have a high risk for developing the disease or who have osteoporosis.
Raloxifene hydrochloride is also approved to prevent and treat:
Osteoporosis in postmenopausal women.
Raloxifene hydrochloride is also being studied in the treatment of other types of cancer.
Evista (Raloxifene hydrochloride) is an estrogen agonist / antagonist, referred to as a Selective estrogen receptor modulator (SERMs) and belongs to the benzothiophene class of compounds. The biological actions of Raloxifene are largely settlement through binding to estrogen receptors. This binding results in the activation of Pathways to estrogenic in some tissues (agonists) and and the Blockade of estrogenic Foundation in other tissues (the antagonist). The agonistic or antagonistic activity of raloxiffene depends on the extent of the recruitment of coactivators and corepressors to the estrogen receptor (ER), the promoter of the target gene. Raloxifene appears to act as an estrogen agonist in bone. It decreases bone resorptive and bone Turnovo, increases bone mineral density and decreases fracture incidence.
4. COA :
|Appearance||White &off-white powder||Conform|
|Soluble in 10% sodium hydroxide solution. Slightly Soluble in methanol. Insoluble in water|| |
|Tests||Loss on drying||≤0.5%||0.4%|
|Residue on ignition||≤0.1%||0.06%|
|Raloxifene Impurity1||≤0.20 %||0.10%|
|Any unspecified individual impurity 2||≤0.10%||Max. 0.08%|
5. Competitive Advantages:
As a pharmaceutical manufacturer, Nanjing Bangnuo Biotechnology Co., Ltd. specializes in steroid raw material and pharmaceutical raw materials. Over the years, we have been committed to provide the top cost-effective products and services to our customers.
Our products have been approved by many organizations and institutions, such as ISO9001 and SGS, etc. And our products have been exported to all over the world. The products can be served in gym fields, athletes fields and medical institutions, etc.
Discreet package will be adopted to ensure the delivery safety.
Shipping: Within 24 hours after receiving the payment by express delivery (DHL, TNT, FedEx, HKEMS, UPS, EMS, etc.)
Payment Terms: T/T, West Union, Money Gram and Bitcoin.
Please feel free to inquire us for more details.